Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/01/2003EP1200447B1 Oxazinocarbazoles for the treatment of cns diseases
10/01/2003EP1200435B1 Purine derivatives inhibitors of tyrosine protein kinase syk
10/01/2003EP1105393B1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
10/01/2003EP1089996B1 Paroxetine methanesulfonate acetonitrile solvate 1:1
10/01/2003EP1071665B1 Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes
10/01/2003EP1056467B1 Method for the treatment of diseases or disorders of the inner ear
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0996621B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
10/01/2003EP0977558B1 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/01/2003EP0946589B1 Inhibitors of peptide binding to mhc class ii proteins
10/01/2003EP0944595B1 5-cyclo indole compounds as 5-ht1d receptor ligands
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003EP0758882B1 Use of n-acetyl-l-cysteine for lightening hyperpigmented skin
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1446216A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
10/01/2003CN1446108A Pharmaceutical form comprising a support material and at least a cell regulating factor and/or cell proliferation promoter
10/01/2003CN1446106A Method of treating estrogen receptor positive carcinoma
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
10/01/2003CN1446100A Method for treating movement disorder
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446091A Daily treatment for erectile dysfunction using PDES inhibitor
10/01/2003CN1446087A Use of lipase inhibitors
10/01/2003CN1446086A Use of estramustine phosphate in treatment of bone metastasis
10/01/2003CN1446084A Treatment of insulin resistance syndrome
10/01/2003CN1446080A Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
10/01/2003CN1445242A Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition
10/01/2003CN1445239A Mutain of human stem cell growth fcator as well as its preparing method and medicine combination
10/01/2003CN1445225A Intermediate for preparing benzothiophene amide derivate
10/01/2003CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same
10/01/2003CN1122668C Epothilone derivatives and their preparation method and their use as antitumor agents
10/01/2003CN1122666C New 2,3-dioxide indanol compounds, process for their preparation and pharmaceutical compositions containing them
10/01/2003CN1122662C Arylsulfonylamino hydroxamic acid derivatives
10/01/2003CN1122513C Use of compound in medicine for preparation of inhibiting pathological conditions
10/01/2003CN1122510C Medicinal composition for treating AIDS and its application
09/2003
09/30/2003US6627774 N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
09/30/2003US6627769 Antiproliferative agents
09/30/2003US6627754 Pyrrolo[2,3-d]pyrimidine compounds
09/30/2003US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it
09/30/2003US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease
09/30/2003US6627731 Thrombin derived polypeptides; compositions and methods for use
09/30/2003US6627661 Use of 5HT-6 antagonists
09/30/2003US6627658 Administration of an effective amount of 15-epi-16-(para-fluoro)-phenoxy-lipoxin A4, Lipoxin-A4, 15-epi-lipoxin4 or 15-R/S-methyl-lipoxin4 or salts, esters, amides, carboxylic acids or prodrugs to treat angiogenesis
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627653 Anticonvulsant derivatives useful for the treatment of depression
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/30/2003US6627644 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627633 The compounds also are potent inhibitors of human cellular proliferation. As such, the compounds constitute pharmaceutical compositions with a pharmaceutically acceptable carrier. Such compounds are useful in inhibiting cellular
09/30/2003US6627629 Useful for the treatment or prevention of asthma and other allergic diseases.
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627625 Beta-lactam antibiotics and beta -lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidenced inter by anxiolytic and antiaggressive behavior modification ans enhanced cognition
09/30/2003US6627621 Neutrophil function inhibitors
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627439 Cancer diagnosis, therapy; Dna vaccine
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627231 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627196 Dosages for treatment with anti-ErbB2 antibodies
09/30/2003US6627187 Containing an amino acid as a stabilizer; long term storage stability
09/30/2003US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF)
09/30/2003US6626932 Therapeutic light source and method
09/30/2003CA2279796C Process for the preparation of substituted pyridines
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/30/2003CA2114630C Steroid sulphatase inhibitors
09/30/2003CA2106073C Composition for promoting tissue repair and regeneration
09/25/2003WO2003079020A2 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078630A1 INHIBITION OF THE β3 SUBUNIT OF L-TYPE CA2+ CHANNELS
09/25/2003WO2003078624A1 Llpl gene and novel use of its gene product
09/25/2003WO2003078619A1 Hybrid and single chain meganucleases and use thereof
09/25/2003WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
09/25/2003WO2003078457A1 MUTEINS OF THE C5a ANAPHYLATOXIN, NUCLEIC ACID MOLECULES ENCODING SUCH MUTEINS, AND PHARMACEUTICAL USES OF MUTEINS OF THE C5a ANAPHYLATOXIN
09/25/2003WO2003078441A1 Aminomethyl-substituted thiazolobenzimidazole derivative
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078434A1 Ethane-1,2-diamino-bis[(2r)-2-bromo-3-phenylpropanoate], method for production and use thereof
09/25/2003WO2003078431A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
09/25/2003WO2003078429A1 Micronized crystalline tiotropium bromide
09/25/2003WO2003078428A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078422A1 Novel pyridone derivative
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078419A1 N-substituted benzothiophenesulfonamide derivative
09/25/2003WO2003078415A1 Cyclic hemiacetal derivative and use thereof
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078410A1 Cyclic etheramine derivatives and their use for the treatment of tumors
09/25/2003WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
09/25/2003WO2003078408A1 Crystalline parecoxib sodium
1 ... 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 ... 1564